IPP Bureau
Thyrocare secures NABL accreditation for its Labs
By IPP Bureau - December 27, 2024
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
Sumitomo Pharma America receives USFDA approval of vibegron for benign prostatic hyperplasia
By IPP Bureau - December 27, 2024
GEMTESA is the first and only beta-3 agonist approved for the treatment of men with OAB symptoms who are receiving pharmacological therapy for BPH
Yatharth Hospital becomes Uttar Pradesh's first JCI-accredited hospital
By IPP Bureau - December 26, 2024
JCI accreditation is recognized globally
Akums signs Rs. 1,760 crore CDMO agreement with a leading global pharma company
By IPP Bureau - December 26, 2024
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
Kwality Pharmaceuticals receives approval for Tamoxifen 20mg Tablet in South Africa
By IPP Bureau - December 26, 2024
This approval is a significant achievement in expanding the availability of this critical therapeutic,
Aarti Drugs receives EIR from USFDA for Tarapur API facility
By IPP Bureau - December 26, 2024
This facility is considered to be in a minimally acceptable state of compliance with regard to current GMP
SVU to organise International Conference on Clinical Translation of Biomaterial-based Therapeutics and Devices on 6-7 Feb, 2025
By IPP Bureau - December 26, 2024
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Antara partners with Dr. Lal PathLabs to strengthen its geriatric care services
By IPP Bureau - December 24, 2024
This curated geriatric care package - Varishtha Aarogya Vardaan -- includes a comprehensive range of essential blood tests specifically curated for seniors.
Tejnaksh Healthcare’s MD granted Indian patent for Pflow
By IPP Bureau - December 24, 2024
Pflow is a revolutionary, disposable, and portable home based urine flow measurement test
Ikena Oncology and Inmagene Biopharmaceuticals announce agreement for merger
By IPP Bureau - December 24, 2024
The transaction is expected to result in approximately $175 million to support further development of IMG-007
BASF sells food and health performance ingredients business to Louis Dreyfus Company
By IPP Bureau - December 24, 2024
Divestment is part of BASF’s strategic portfolio optimization
Syensqo and Emulseo collaborate to advance microfluidic technology in healthcare sector
By IPP Bureau - December 24, 2024
Exploring new opportunities within the fast-growing market of microfluidics
KRAIBURG TPE's solutions upraises healthcare products for higher functionality
By IPP Bureau - December 22, 2024
The TPE Tourniquet and TPE Esmark Bandages are renowned for their single-use design,
Alembic Pharmaceuticals receives USFDA final approval for Divalproex Sodium Delayed-Release Capsules
By IPP Bureau - December 22, 2024
Divalproex Sodium Delayed-Release Capsules USP, 125 mg have an estimated market size of US$ 61.1 million for twelve months ending September 2024 according to IQVIA